key: cord-0758948-585a31ts
authors: Ngo, Son Tung; Vu, Khanh B.; Pham, Minh Quan; Tam, Nguyen Minh; Tran, Phuong-Thao
title: Marine derivatives prevent wMUS81 in silico studies
date: 2021-09-08
journal: Royal Society open science
DOI: 10.1098/rsos.210974
sha: 645d44a617dd34d2cbca6099dc6e19c25a18e841
doc_id: 758948
cord_uid: 585a31ts

The winged-helix domain of the methyl methanesulfonate and ultraviolet-sensitive 81 (wMUS81) is a potential cancer drug target. In this context, marine fungi compounds were indicated to be able to prevent wMUS81 structure via atomistic simulations. Eight compounds such as D197 (Tryptoquivaline U), D220 (Epiremisporine B), D67 (Aspergiolide A), D153 (Preussomerin G), D547 (12,13-dihydroxyfumitremorgin C), D152 (Preussomerin K), D20 (Marinopyrrole B) and D559 (Fumuquinazoline K) were indicated that they are able to prevent the conformation of wMUS81 via forming a strong binding affinity to the enzyme via perturbation approach. The electrostatic interaction is the dominant factor in the binding process of ligands to wMUS81. The residues Trp55, Arg59, Leu62, His63 and Arg69 were found to frequently form non-bonded contacts and hydrogen bonds to inhibitors. Moreover, the influence of the ligand D197, which formed the lowest binding free energy to wMUS81, on the structural change of enzyme was investigated using replica exchange molecular dynamics simulations. The obtained results indicated that D197, which forms a strong binding affinity, can modify the structure of wMUS81. Overall, the marine compounds probably inhibit wMUS81 due to forming a strong binding affinity to the enzyme as well as altering the enzymic conformation.

The winged-helix domain of the methyl methanesulfonate and ultraviolet-sensitive 81 (wMUS81) is a potential cancer drug target. In this context, marine fungi compounds were indicated to be able to prevent wMUS81 structure via atomistic simulations. Eight compounds such as D197 (Tryptoquivaline U), D220 (Epiremisporine B), D67 (Aspergiolide A), D153 (Preussomerin G), D547 (12,13-dihydroxyfumitremorgin C), D152 (Preussomerin K), D20 (Marinopyrrole B) and D559 (Fumuquinazoline K) were indicated that they are able to prevent the conformation of wMUS81 via forming a strong binding affinity to the enzyme via perturbation approach. The electrostatic interaction is the dominant factor in the binding process of ligands to wMUS81. The residues Trp55, Arg59, Leu62, His63 and Arg69 were found to frequently form non-bonded contacts and hydrogen bonds to inhibitors. Moreover, the influence of the ligand D197, which formed the lowest binding free energy to wMUS81, on the structural change of enzyme was investigated using replica exchange molecular dynamics simulations. The obtained results indicated that D197, which forms a strong binding affinity, can modify the structure of wMUS81. Overall, the marine compounds probably inhibit wMUS81 due to forming a strong binding affinity to the enzyme as well as altering the enzymic conformation.

The AutoDockTools 1.5.6 was employed to topologize for both receptor and ligands [48] . The grid centre was selected as the residue Leu62 sidechain centre of mass (cf. figure 1) referring to the recent work [49] . The grid size was 2.6 × 2.6 × 2.0 nm (figure 1). The docking parameter, exhaustiveness, was chosen as 8 referred to the previous work [37] . During the docking simulations, the ligand was flexible but the receptor was fully rigid.

GROMACS 2019.4 using graphics processing unit (GPU) computing was employed to simulate the dynamics of the wMUS81-inhibitor system in solution [50] . The complex was topologized according to the recent studies [49, 51] . In particular, the wMUS81/ions and water molecules were parametrized via the Amber99SB-ILDN force field [52] and the TIP3P water model [53] , respectively. Besides that, the inhibitor was parametrized using the general Amber force field (GAFF) [54] using a combination of AmberTools18 [55] and ACPYPE [56] packages. Ligand atomic charges were computed via the restrained electrostatic potential (RESP) method [57] using quantum mechanical calculations with the level of theory at B3LYP/6-31G(d,p). The implementation of the force fields is a suitable selection for free energy determination [58, 59] . The wMUS81 complex was placed in a dodecahedron box with a size of 7.0 × 7.0 × 7.0 nm (cf. figure 2), being measured with a periodic boundary condition [60] . Four Na + ions were approximately used to neutralize the system. Overall, the wMUS81 system consists of ca 25 000 atoms. Moreover, the system comprising the ligand in solution was also prepared and simulated. The size of the ligand in solution was ca 74 nm 3 comprising ca 7200 atoms in total.

The MD parameters were referred to the prior works [41, 61] . In particular, the non-bonded pair between surrounding atoms is calculated within a radius of 9 Å with the pair list is reorganized every 5 ps during the MD simulations. The MD integral was performed with 2 fs timestep. The van der Waals (vdW) interaction is affected within a cut-off of 9 Å. The coulombic interaction is implemented via the particle mesh Ewald method [62] within a non-bonded pair radius. The MD temperature is 310 K. The complex was equilibrated via three steps as followed as the energic minimization, canonical (NVT) simulations and isobaric-isothermal (NPT) simulations. The solvated complex and ligand systems were then mimicked over 20 and 5 ns of MD simulations, respectively. The simulations were repeated two times.

The REMD simulations were manipulated to investigate the structural change of the wMUS81 entire phase space when the inhibitor is present and absent. During the simulations, 32 replicas were simultaneously mimicked in various temperatures ranging from 310.00 to 414.26 K, which the list was suggested by a webserver [63] royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 210974 simulations were carried out with a length of 100 ns each replica (6400 ns for two systems in total). The acceptance ratio was 15% approximately. Therefore, the wMUS81 system easily escapes local minima due to exchanging shapes with higher temperature copies. The exchange was attempted every 1 ps if the exchange probability between adjacent replicas satisfies the Metropolis criterion [33] . The inputs of REMD simulations are the equilibrated conformations of isolated wMUS81 or wMUS81+inhibitor in solution, which were the final structures of NPT simulations.

The protonation states of inhibitors were predicted using a tool of the ChemAxon protocol as well as chemicalize (chemicalize was used for the prediction of chemical properties; see https://chemicalize. com/, developed by ChemAxon). The non-bonded contact between ligands and residual elements of wMUS81 was totalized when the pair between non-hydrogen atoms is smaller than 4.5 Å. Twodimensional interaction diagrams were prepared via the free Maestro [64] . The binding free energy between inhibitors and wMUS81 was determined via the double-annihilation binding free method [33, 40, 65] . The details of FEP approach were reported in the previous work [33] . In particular, the coupling parameter λ was used to modify the Hamiltonian of the system from bound state to unbound state. The free energy change of the process was summed using the Bennet acceptance ratio method [66] . The λ-modification simulations were thus performed to calculate the free energy change of ligand-annihilation from the solvated complex and ligand systems. The difference of free energy change of the two processes is the binding free energy of ligands to receptors. Eight values of λ, used to change electrostatic interaction, are 0.00, 0.10, 0.20, 0.35, 0.50, 0.65, 0.80 and 1.00. Nine values of λ, used to change vdW interaction, are 0.00, 0.10, 0.25, 0.35, 0.50, 0.65, 0.75, 0.90 and 1.00. The free energy landscape (FEL) was built via the GROMACS tool [50] with two reaction coordinates being the first and the second eigenvectors estimated by the principal component analysis (PCA) method [67] .

As mentioned above, molecular docking simulations were performed to preliminarily evaluate the ligand-binding poses and affinities to wMUS81. The outcomes are shown in table 1 and electronic  supplementary material, table S1 . Here, Vina, a free and popular docking package with a successfuldocking rate of up to 81% [35] [36] [37] , was executed to find binding poses and affinities of 563 marine compounds to receptor referring to the recent work [49] . The docking energies range from −2.8 to −7.4 kcal mol −1 with a median of −5.17 ± 0.63 kcal mol −1 , the calculated error is the standard deviation. The distribution of docking energies is thus presented in figure 3 . According to the docking results, 3% top-lead compounds, having DG Vina , À6:0 kcal mol −1 , possibly bind to wMUS81 with a large amount of free energy difference of binding. Although, as mentioned above, Vina approach regularly adopts appropriate results, the affinity of 16 compounds to wMUS71 would be further evaluated using MD/REMD simulations. The strategy is normally applied since the docking simulations implement many approximations to enhance the calculation performance such as a rigid receptor, a limited number of trial ligand positions, employed united-atoms force field, using implicit solvent model, etc.

D547 system wMUS81 + D547 system royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 210974

As mentioned above, the ligand-binding affinity of the 16 top-lead compounds to wMUS81 would be re-evaluated using MD simulations (table 1) due to some limitations of the docking approach as mentioned above. The outcome of Vina is an appropriate result since forming a good correlation with the FEP calculations (cf. figure 4) , which approach is known as the most accurate technique [28] . The obtained Pearson correlation is R Vina FEP ¼ 0:68 + 0:17, in which the computed error was estimated via the bootstrapping method with 1000 rounds of calculations [68] . It may argue that Vina is a suitable solution for explorative determining ligand-binding affinity to wMUS81 quickly.

Two-dimensional interaction diagrams between inhibitors and wMUS81 were prepared using the free Maestro package [64] and the results are shown in figure 5 and electronic supplementary material, table S3. Eight compounds shown in figure 5 are potential inhibitors for wMUS81 via MD-refined simulations (see below). Over these diagrams, it may argue that the residues Arg59, Ser60, Leu62, His63, Asn65, Val67, Leu68 and Arg69 play a critical role in the binding process of ligands to wMUS81. Especially, the residues Arg59, His63 and Arg69 not only form HB contacts with the inhibitors but also adopt π-cation/ π-π contacts to the ligands. 

As mentioned above, the molecular docking simulations were performed using many constraints; the MD simulations were thus manipulated to improve the obtained outcomes [30, 69] . The binding poses of ligands to wMUS81 were used as initial conformations for mimicking complex by GROMACS 2019.4 [50] . The ligand-binding free energy was then assessed via perturbation simulations [33] . In this context, the MD simulations were carried out with a length of 20 and 5 ns for complexed wMUS81-inhibitor and isolated inhibitor in solution, correspondingly. Particularly, almost systems gained the stabilized conformations after half of the MD trajectory (cf. electronic supplementary material, table S2). The intermolecular non-bonded contacts and HBs between receptor residues and inhibitors were probed in order to predict the binding mechanism of ligands to wMUS81. The investigations were carried out over the equilibrium structures of the solvated complexes. The obtained results are described in electronic supplementary material, figure S1, which presents 77 residues forming non-bonded contacts with inhibitors over 5% of the considered structures (34 000 snapshots in total). Among them, 44 residues adopt HBs to inhibitors. The obtained results suggested that inhibitors probably moved the entire surface of wMUS81 during MD simulations, confirming that the simulations were unbiased to any royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 210974 specific conformation. In order to characterize which are the most pivotal residues, we have counted residues that formed more than 10% non-bonded contacts or 2% HBs to inhibitors. Sixteen residues, which are shown in figure 6 , were satisfied with the criteria. We may conclude that the residues Trp55, Arg59, Leu62, His63 and Arg69 are important residues controlling the ligand-binding free energy of ligands to wMUS81 since these residues form at least 26% non-bonded contacts to trial ligands. Moreover, among five residues, both residues Arg59 and Arg69 dominated over the other residues since forming both non-bonded contacts and HBs to inhibitors (cf. figure 6) . Furthermore, probable mutations at these residues could significantly alter the ligand-binding affinity to wMUS81.

In the recent report [49] , the FEP calculations fruitfully evaluated the ligand-binding affinity of ligands to wMUS81 as well as the highest accurate binding free energy approaches [27, 28] . Therefore, in this context, we used FEP simulations to refine the binding free energy of inhibitors to wMUS81. In particular, the equilibrated shapes of complexes and ligands in solution at 20 and 5 ns were used as initial structures of λ-alteration simulations, respectively. The obtained results are reported in table 1, in which the DG FEP falls in the range from −0.66 to −18.83 kcal mol −1 with a median of ca −7.39 kcal mol −1 . Eight compounds were indicated by FEP to form binding affinity larger than −8.0 kcal mol −1 , which would respect to an inhibition constant K i in the micromolar range or smaller (table 1) . Among these compounds, five inhibitors adopted a large binding affinity to wMUS81 with the respective K i in the subnanomolar range. Therefore, we may argue that five compounds named D197, D220, D67, D153 and D547 are highly potent inhibitors preventing the conformation of wMUS81. Besides, three compounds, D152, D20 and D559, are also good candidate ones. Moreover, on average over all compounds, the DG cou and DG vdW values form a median of ca −1.58 and −5.82 kcal mol −1 , correspondingly. However, when considering over eight top-lead compounds, the DG cou and DG vdW values form a median of ca − 7.18 and −6.21 kcal mol −1 , respectively. The electrostatic free energy of binding dominates over the vdW one in controlling the binding process of ligands to wMUS81. It is well consistent with the observation in docking analysis (figure 5).

It should be noted that the stronger ligand-binding to protein means better inhibition [28] . Moreover, the stronger binder normally adopts a strong effect on the protein, resulting in the structural change of protein being recorded [41] . Therefore, in this context, the influence of the ligand D197 on the structure of wMUS81 was investigated using REMD simulations since the ligand formed the largest binding affinity to wMUS81 via FEP calculations. In particular, the structural change of wMUS81 over the REMD simulations [42] were performed with a length of 100 ns each. The conformational ensemble of wMUS81 in the presence of the ligand D197 and absence of the ligand was probed. The first 40 ns of REMD simulations was removed from any analysis to evade the initial bias. Figure 7 describes the FELs and representative structures of wMUS81 over two systems. The FEL was produced by two principal components, which were obtained from the PCA analysis. Absolutely, the ligand significantly influences royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 210974

the FEL of wMUS81 and also alters the optimized structures of the enzyme. Although the β-sheet regions of wMUS81 were unchanged, the α-structure domains were rigidly impacted (figure 7). In particular, without the presence of the ligand, wMUS81 forms α-structure at sequences 10-23, 33-39, 54-64 and 80-91, while the corresponding sequences of wMUS81+D197 are 10-23, 33-43, 50-64 and 80-87. The structural alteration probably changes the biological function of wMUS81. The strong binding ligand to wMUS81 is thus able to inhibit the activity of the enzyme.

In this context, the inhibitory effect of marine compounds to wMUS81 was investigated using rigorous computational approaches. Initially, the binding affinity of marine compounds to wMUS81 was preliminarily investigated using AutoDock Vina. The binding poses between wMUS81 and the 16 topleads inhibitors were then used as initial conformations of atomistic MD simulations. The binding free energy was calculated via the FEP scheme revealing that five compounds, D197, D220, D67, D153 and D547, are highly potent inhibitors preventing wMUS81. Moreover, three compounds, D152, D20 and D559, are also good candidate ones, because the predicted inhibition constant of them is in submicromolar affinity (DG FEP is smaller than −9.50 kcal mol −1 ). The electrostatic interaction is the dominant factor in the binding of ligands to wMUS81. Over atomistic simulations, it was found that the residues Trp55, Arg59, Leu62, His63 and Arg69 of wMUS81 probably play an important role in the binding process of ligands to wMUS81 since frequently forming non-bonded contacts and HBs to inhibitors. Especially, Arg59 and Arg69 are the most critical elements governing the binding affinity of ligands to wMUS81.

The influence of the ligand D197, which formed the largest binding affinity to wMUS81, on the conformational ensemble of the protein was also assessed via REMD simulations based on the royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 210974 hypothesis that the stronger binder will adopt more effect on the stable shape of the protein. Absolutely, the ligand D197 significantly altered the FEL of wMUS81 and also changed the stable structure of the protein. It may be argued that the ligand D197, which forms a strong binding affinity, can change the biological function of wMUS81 due to the change in the enzymic structure.

Data accessibility. The data are available at https://doi.org/10.5061/dryad.m63xsj41r [70] , in particular, the docking results (used as the initial structures of MD simulations), MD-refined structures (used as the initial structure for FEP calculations) and REMD-refined structures.

Structure-specific endonucleases Xpf and Mus81 play overlapping but essential roles in DNA repair by homologous recombination

Mus81 endonuclease localizes to nucleoli and to regions of DNA damage in human S-phase cells

A winged helix domain in human MUS81 binds DNA and modulates the endonuclease activity of MUS81 complexes

MUS81 inhibition increases the sensitivity to therapy effect in epithelial ovarian cancer via regulating CyclinB pathway

MUS81 participates in the progression of serous ovarian cancer associated with dysfunctional DNA repair system

Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer

Down-regulation of Mus81 as a potential marker for the malignancy of gastric cancer

Inhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell lines

Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S-phase arrest and promoting apoptosis through CHK1 pathway

Mus81 knockdown sensitizes colon cancer cells to chemotherapeutic drugs by activating CHK1 pathway

MUS81 is associated with cell proliferation and cisplatin sensitivity in serous ovarian cancer

Inhibition of protein misfolding and aggregation by natural phenolic compounds

Identifying natural compounds as multi-targetdirected ligands against Alzheimer's disease: an in silico approach

Metabolomic profile and nucleoside composition of Cordyceps nidus sp. nov. (Cordycipitaceae): a new source of active compounds

A natural product inhibits the initiation of alpha-synuclein aggregation and suppresses its toxicity

A new face for old antibiotics: tetracyclines in treatment of amyloidoses

Effects of several quinones on insulin aggregation

A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage

Aromatic small molecules remodel toxic soluble oligomers of amyloid β through three independent pathways

EGCG inhibits the oligomerization of amyloid beta

Drugs from the deep: marine natural products as drug candidates

Marine pharmacology

Drug development from marine natural products

Natural product and natural product derived drugs in clinical trials

Potential inhibitors for SARS-CoV-2 Mpro from marine compounds

Molecular design of anticancer drugs from marine fungi derivatives

Ligand-binding affinity estimates supported by quantummechanical methods

2020 Thermodynamics and kinetics of drug-target binding by molecular simulation

Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2

Estimation of the ligandbinding free energy of checkpoint kinase 1 via non-equilibrium MD simulations

Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations

Computer-aided drug design methods

Oversampling free energy perturbation simulation in determination of the ligand-binding free energy

Estimating the ligand-binding affinity via λ-dependent umbrella sampling simulations

Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

Computational proteinligand docking and virtual drug screening with the AutoDock suite

Autodock Vina adopts more accurate binding poses but Autodock4 forms better binding affinity

Evaluation of AutoDock and AutoDock Vina on the CASF-2013 benchmark

Improving the accuracy of AutoDock Vina by changing the empirical parameters

Absolute FKBP binding affinities obtained via non-equilibrium unbinding simulations

Replica-exchange molecular dynamics method for protein folding

PubChem substance and compound databases

Bioactive compounds from marine bacteria and fungi

Marine fungi: a source of potential anticancer compounds. Front. Microbiol. 8, e2536

Bioactive compounds isolated from marine-derived microbes in China

Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina

AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility

Computational investigation of possible inhibitors of the winged-helix domain of MUS81

GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19-25

Computational determination of potential inhibitors of SARS-CoV-2 main protease

Motional timescale predictions by molecular dynamics simulations: case study using proline and hydroxyproline sidechain dynamics

Comparison of simple potential functions for simulating liquid water

Development and testing of a general amber force field

ACPYPE-AnteChamber PYthon Parser interfacE

A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model

Force field benchmark of amino acids: I. Hydration and diffusion in different water models

Force field benchmark of amino acids: 2. Partition coefficients between water and organic solvents

Influence of various force fields in estimating the binding affinity of acetylcholinesterase inhibitors using fast pulling of ligand scheme

2021 Benchmark of popular free energy approaches revealing the inhibitors binding to SARS

Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems

A temperature predictor for parallel tempering simulations

Schrödinger release 2020-4: Maestro

High-temperature equation of state by a perturbation method: I. Nonpolar gases

Efficient estimation of free energy differences from Monte Carlo data

Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case

Bootstrap methods: another look at the jackknife

Computational investigation of gantenerumab and crenezumab recognition of Aβ fibrils in Alzheimer's disease brain tissue

Marine derivatives prevent wMUS81 in silico studies. Dryad, Dataset. (doi:10.5061/ dryad.m63xsj41r) royalsocietypublishing.org/journal